NCT06889740 is a NA clinical trial of NMNH in Healthy Aging, sponsored by EffePharm LTD.

Who is sponsoring NCT06889740?

NCT06889740 is sponsored by EffePharm LTD.

What drugs are being tested in NCT06889740?

Interventions in NCT06889740: NMNH, Placebo.

What condition does NCT06889740 study?

NCT06889740 studies Healthy Aging.

Is NCT06889740 still recruiting?

NCT06889740 is currently completed. Last updated 4 July 2025.

Last reviewed 2025-07-04 · How we verify

NCT06889740

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Safety, Tolerability, and Efficacy of UthPeak NMNH (Reduced Nicotinamide Mononucleotide) in Healthy Adult Participants

Completed NA Last updated 4 July 2025

What this trial tests

NA trial testing NMNH in Healthy Aging in 80 participants. Completed in 25 January 2025.

Timeline

8 July 2024

Primary endpoint
8 December 2024

25 January 2025

Quick facts

Lead sponsor	EffePharm LTD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	80
Start date	8 July 2024
Primary completion	8 December 2024
Estimated completion	25 January 2025
Sites	2 locations across India

Drugs / interventions tested

NMNH
Placebo

Conditions studied

Healthy Aging — all drugs for Healthy Aging →

Sponsor

EffePharm LTD

Who can join

Adults 40 to 65, any sex, with Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to assess the safety and tolerability of NMNH as a dietary supplement for human consumption. The current study aims to comprehensively evaluate its potential effects on pharmacokinetics, physical performance, biological age and overall quality of life. These findings will expand our understanding of NMNH therapeutic potential and guide its future clinical applications in anti-aging interventions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Aging

Currently open trials in the same condition.

NCT07515495 — Effectiveness of Intensive Tutoring vs. Flexible Self-Learning on Digital Health Literacy and Self-Efficacy for "My Heal · NA · recruiting
NCT07231783 — The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults · NA · recruiting
NCT07308353 — Comparative Effects Of Exergaming And Otago Exercise On Anticipatory Postural Control And Sensory Integration In Older A · NA · active not recruiting
NCT07207044 — FAXAGE: Fasting And Exercise To Slow Aging In Humans · NA · recruiting
NCT07151365 — Plant-based Diets and Healthy Aging · recruiting

Other EffePharm LTD trials

Trials by the same sponsor.

NCT04228640 — Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06889740 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by EffePharm LTD
Last refreshed: 4 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06889740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing